Alcon
ALC----
Alcon (ALC)
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Visio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Alcon Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$87.3228.58%
Forecast & RatingBuy
26analysts
- Strong buy65.38%
- Buy19.23%
- Hold11.54%
- Sell0.00%
- Strong sell3.85%
News
- Market Beat · Jul 10 at 09:01 PM
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
- Tip Ranks · Jul 7 at 04:25 AM
RxSight: Alcon Partnership and Margin Improvements Offset Near-Term Sales Shortfall; Buy Rating and $11 Price Target Reiterated
- benzinga_article · Jul 6 at 03:35 PM
RxSight shares are trading lower after the company issued Q2 and FY26 sales guidance. The company announced a non-exclusive collaboration with Alcon to jointly develop adjustable presbyopia-correcting intraocular lenses.
- Unusual Whales · Jul 6 at 03:17 PM
RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
- PUBT · Jul 6 at 03:15 PM
Alcon, RxSight collaborate to develop adjustable presbyopia-correcting intraocular lenses
- PUBT · Jul 6 at 03:15 PM
RxSight forecasts 2026 revenue of $140 million-$160 million, cuts sales outlook to $110 million-$120 million
